NCT06538038 2026-03-16
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
Recruiting
PrECOG, LLC.
Fundación GECP
Bristol-Myers Squibb
University Medical Center Groningen
CHA University
City of Hope Medical Center